L-carnitine supplementation in dialysis patients: does the evidence justify its use?

@article{Steinman2005LcarnitineSI,
  title={L-carnitine supplementation in dialysis patients: does the evidence justify its use?},
  author={Theodore I. Steinman},
  journal={Seminars in dialysis},
  year={2005},
  volume={18 1},
  pages={1-2}
}
Beginning January 1, 2003, the Centers for Medicare and Medicaid Services (CMS) initiated a national coverage determination for the use of levo-carnitine (L-carnitine) in end-stage renal disease (ESRD) patients as a supplement for individuals defined as having a carnitine deficiency, accompanied by either erythropoietin (EPO)-resistant anemia and/or… CONTINUE READING